Managing Upper Respiratory Diseases

Treatment Options
Appropriate treatment of patients with allergy-like nasal symptoms begins with an accurate assessment of specific IgE antibodies through testing. Management decisions will differ for the allergic patient and the non-allergic patient, so specific IgE testing to help the clinician rule in or rule out an allergic etiology can help guide treatment.

Therapeutic technologies now available to treat allergy and allergy-related diseases have become increasingly specific in their mechanism of action, and demand a comparable increase in the diagnostic specificity. It’s important to remember that medications designed to target the allergic process are considered ineffective in patients without atopy.1 With a negative specific IgE blood test result, the clinician can avoid prescribing costly non-sedating antihistamines or leukotriene atagonists that will offer no benefit to the non-allergic patient.